These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22258871)

  • 1. Cyclooxygenase isoenzyme-2 and vascular endothelial growth factor are associated with poor prognosis in esophageal adenocarcinoma.
    Prins MJ; Verhage RJ; ten Kate FJ; van Hillegersberg R
    J Gastrointest Surg; 2012 May; 16(5):956-66. PubMed ID: 22258871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy.
    Gaffney DK; Haslam D; Tsodikov A; Hammond E; Seaman J; Holden J; Lee RJ; Zempolich K; Dodson M
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):922-8. PubMed ID: 12829126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer.
    Kulke MH; Odze RD; Mueller JD; Wang H; Redston M; Bertagnolli MM
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1579-86. PubMed ID: 15173710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in Chinese patients with esophageal squamous cell carcinoma.
    Cui Y; Dong C; Wu BQ; Duan XC; Shi G; Gong M; Wang TY
    J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C44-8. PubMed ID: 26323923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucin 1 and vascular endothelial growth factor C expression correlates with lymph node metastatic recurrence in patients with N0 esophageal cancer after Ivor-Lewis esophagectomy.
    Sun ZG; Wang Z; Liu XY; Liu FY
    World J Surg; 2011 Jan; 35(1):70-7. PubMed ID: 21046381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of the number of negative lymph nodes in esophageal cancer patients after transthoracic resection.
    Hsu PK; Huang CS; Wang BY; Wu YC; Chou TY; Hsu WH
    Ann Thorac Surg; 2013 Sep; 96(3):995-1001. PubMed ID: 23866797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas.
    Driessen A; Landuyt W; Pastorekova S; Moons J; Goethals L; Haustermans K; Nafteux P; Penninckx F; Geboes K; Lerut T; Ectors N
    Ann Surg; 2006 Mar; 243(3):334-40. PubMed ID: 16495697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus.
    Buskens CJ; Van Rees BP; Sivula A; Reitsma JB; Haglund C; Bosma PJ; Offerhaus GJ; Van Lanschot JJ; Ristimäki A
    Gastroenterology; 2002 Jun; 122(7):1800-7. PubMed ID: 12055587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Tumor Vascular Endothelial Growth Factor Expression Is Associated With Poorer Clinical Outcomes in Resected T3 Gastric Adenocarcinoma.
    Lin C; Zhang Z; Xu Y; Wang R; Chen S; Gao J; Wang D; Huang Q; Tu X; Wang L
    Am J Clin Pathol; 2016 Sep; 146(3):278-88. PubMed ID: 27543975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma.
    Barbetta A; Schlottmann F; Nobel T; Sewell DB; Hsu M; Tan KS; Gerdes H; Shah P; Bains MS; Bott M; Isbell JM; Jones DR; Molena D
    Ann Thorac Surg; 2018 Jul; 106(1):172-177. PubMed ID: 29627387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implications.
    Gou HF; Chen XC; Zhu J; Jiang M; Yang Y; Cao D; Hou M
    J Exp Clin Cancer Res; 2011 Jan; 30(1):14. PubMed ID: 21272377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclo-oxygenase-2 expression in esophageal adenocarcinoma as a determinant of clinical outcome following esophagectomy.
    France M; Drew PA; Dodd T; Watson DI
    Dis Esophagus; 2004; 17(2):136-40. PubMed ID: 15230726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targets for molecular therapy in esophageal squamous cell carcinoma: an immunohistochemical analysis.
    Boone J; van Hillegersberg R; Offerhaus GJ; van Diest PJ; Borel Rinkes IH; Ten Kate FJ
    Dis Esophagus; 2009; 22(6):496-504. PubMed ID: 19302210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between vascular endothelial growth factor C expression and prognosis in patients with esophageal squamous cell carcinomas after Ivor-Lewis esophagectomy.
    Sun ZG; Wang Z; Zhang M
    Asia Pac J Clin Oncol; 2012 Dec; 8(4):e68-76. PubMed ID: 22897688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANPEP/CD13 Expression as a Marker of Lymphovascular Invasion and Survival in Esophageal Adenocarcinoma.
    Goltsov AA; Maru DM; Katkhuda R; Duose DY; Luthra R; Correa AM; Wang F; Futreal PA; Hofstetter WL
    Ann Thorac Surg; 2024 Jul; 118(1):241-251. PubMed ID: 37806335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HuR status is a powerful marker for prognosis and response to gemcitabine-based chemotherapy for resected pancreatic ductal adenocarcinoma patients.
    Richards NG; Rittenhouse DW; Freydin B; Cozzitorto JA; Grenda D; Rui H; Gonye G; Kennedy EP; Yeo CJ; Brody JR; Witkiewicz AK
    Ann Surg; 2010 Sep; 252(3):499-505; discussion 505-6. PubMed ID: 20739850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma.
    Ong CA; Shapiro J; Nason KS; Davison JM; Liu X; Ross-Innes C; O'Donovan M; Dinjens WN; Biermann K; Shannon N; Worster S; Schulz LK; Luketich JD; Wijnhoven BP; Hardwick RH; Fitzgerald RC
    J Clin Oncol; 2013 Apr; 31(12):1576-82. PubMed ID: 23509313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma.
    Feber A; Xi L; Pennathur A; Gooding WE; Bandla S; Wu M; Luketich JD; Godfrey TE; Litle VR
    Ann Thorac Surg; 2011 May; 91(5):1523-30. PubMed ID: 21420070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor (VEGF) and cyclooxygenase 2 (COX 2) immunostaining in ovarian cancer.
    Whynott RM; Manahan P; Geisler JP
    Eur J Gynaecol Oncol; 2016; 37(2):164-6. PubMed ID: 27172738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence or low IGF-1R-expression in esophageal adenocarcinoma is associated with tumor invasiveness and radicality of surgical resection.
    De Bruijn K; Biermann K; Shapiro J; Dogan F; Spaander M; Janssen J; Wijnhoven B; Borsboom G; Hofland L; van Eijck C
    J Surg Oncol; 2015 Jun; 111(8):1047-53. PubMed ID: 26082409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.